Validation and evidence
C-POLAR and NanoFlashing™ questions, with the company’s answers and the sources they come from.
Last reviewed: .
What result does the Validation page report for viruses, bacteria and fungal spores?
The Validation page reports: “Independent testing shows NanoFlashing™ destroys up to 99.99% of a broad spectrum of viruses, bacteria and fungal spores through a physical mechanism.”
It names the conditions tested and the institutions that tested them, and each result belongs to the article named in its own report and to its standard where the report names one. The mechanism is set out in the company’s statements: “The filter is intended to destroy the viruses, bacteria and fungal spores it captures. It destroys them on direct contact with the positive electric charge, by physical means, and only while the organism is captured by the positive electric charge.” The numbered reports behind the pathogen section include these. Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020, tested a nonwoven filter medium against influenza A virus (H3N2) under ISO 18184:2014. Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026, a laboratory accredited to ISO/IEC 17025, tested a MERV 15A filter medium under ISO 20743 and ISO 18184. Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026, tested a VOLZ PROsyntex PLUS PM1 70 filter medium against Aspergillus brasiliensis and Aspergillus niger under ISO 13629-2:2014. The Guangdong report records a logarithm of antiviral activity of 4.34 for that nonwoven filter medium under ISO 18184:2014. ISO 18184 measures virus recovered from treated textile against an untreated control; it is a contact test on the medium, not an airborne or in-use result. The TZÚ report records antibacterial activity values of A = 6.4 against Staphylococcus aureus and A = 4.4 against Klebsiella pneumoniae under ISO 20743, absorption method, and an antiviral activity value of Mv = 3.30 against bacteriophage Phi6 under ISO 18184, for that MERV 15A filter medium. An activity value is a difference against an untreated control fabric. It is not a percentage destroyed and not an airborne result. The Viruses page shows airborne virus at 1.3 m/s airflow, NanoFlashing™ beside a control, and states: “NanoFlashing™ captures the virus, and destroys it.” The Mold page shows airborne mold spores at 1.6 m/s airflow, NanoFlashing™ beside a control, and states: “NanoFlashing™ captures the mold, and destroys it.” The Mold page also states that researchers at Massachusetts General Hospital and Harvard Medical School, in a study with funding from the U.S. National Institutes of Health, tested NanoFlashing™ with more than 100 million live, dry spores driven in by fast-moving air. The IVAMI report records an antifungal activity value of 4.40 for each strain on that filter medium, by the plate-count absorption method under ISO 13629-2:2014, against an untreated control; it is a contact test on the medium, not an airborne or in-use result. Hong Kong Metropolitan University, Test Report IRITS202112110001, 11 December 2021, tested a spunlace nonwoven against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa with reference to BS EN ISO 20743:2013 (transfer method), after accelerated ageing to ASTM F1980-16 for 64 days at 60 °C, and reported: “No significant deterioration of antimicrobial activity was observed after accelerated aging”. It is a contact test on fabric, not an air-filter or airborne result. Two further reports carry no number. Tampere University, Department of Virology, report dated 1 April 2021, tested a treated material against human coronavirus 229E and Coxsackievirus B6. Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, report dated 29 April 2021, tested a treated material under ISO 18184. For Harvard Medical School, Massachusetts General Hospital and the University of Minnesota, the citable record is the peer-reviewed paper: Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23. The paper reports laboratory results on SARS-CoV-2 in contact with treated textile, on aerosolised bovine coronavirus passed through a test filter in a wind tunnel, and on bacterial viability on treated textiles; each result belongs to the article that was tested. Scientific Reports (2023) 13:13947 compared a C-POLAR treated filter with an untreated spunlace nonwoven filter against an aerosolised pseudotyped virus. The conditions the Validation page lists as tested are heavy dust loaded, fast air flow, used filter for 1 year, after 60 washes, after 2 years of storage, and after 60C for 64 days. A reported result applies to the sample that was tested, under the conditions named in the report that recorded it and under its standard where the report names one.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026; Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020; Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026; Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026; Hong Kong Metropolitan University, Test Report IRITS202112110001, 11 December 2021; Tampere University, Department of Virology, report dated 1 April 2021; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, report dated 29 April 2021; Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23, https://journals.asm.org/doi/10.1128/spectrum.04097-23; Scientific Reports (2023) 13:13947; C-POLAR — Viruses, https://cpolar.tech/contaminants/viruses/; C-POLAR — Mold, https://cpolar.tech/contaminants/mold/. A copy may be made available on our review of the request.
Reviewed on .
Sources
- C-POLAR — Validation
- C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026
- Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020
- Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026
- Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026
- Tampere University, Department of Virology, report dated 1 April 2021
- Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, report dated 29 April 2021
- Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23
- Scientific Reports (2023) 13:13947
- Hong Kong Metropolitan University, Test Report IRITS202112110001, 11 December 2021
- C-POLAR — Viruses
- C-POLAR — Mold
What does a reported test result apply to?
A reported result applies only to the test that produced it.
The Terms of Use state it in those words: “A reported result describes only what the identified test found.” That is why each report is named with its institution, and by its number where the report carries one. A report covers the article, the method and the conditions named in it. For example, LMS Technologies, Inc., Pine-Needle Smoke Report, LMS#10471, 20 October 2025, is a single-pass fractional efficiency test in an ASHRAE 52.2 test duct. Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026, a laboratory accredited to ISO/IEC 17025, tested a MERV 15A filter medium under ISO 20743 and ISO 18184. That is a result for that filter medium, not for a finished filter or for the air in a building.
Source: C-POLAR — Terms of Use, https://cpolar.tech/terms/; C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026; Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026. A copy may be made available on our review of the request.
Reviewed on .
Sources
- C-POLAR — Terms of Use
- C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026
- Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026
Does a material or component test establish finished-product performance?
No: a test of a material or a component does not establish the performance of a finished product.
The Terms of Use state it in those words: “A test of C-POLAR material, a component, or a prototype does not establish the performance of a finished product that incorporates it. Construction, processing, storage, wear, cleaning, other components, and actual use may change the result.” The company's filter-medium reports are tests of this kind; for example, Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026, a laboratory accredited to ISO/IEC 17025, tested a MERV 15A filter medium under ISO 20743 and ISO 18184. Development runs configuration by configuration, and each partner controls what is said about the work. The charge is measured on every production run, and the measurement can be repeated on any filter, upon request.
Source: C-POLAR — Terms of Use, https://cpolar.tech/terms/; C-POLAR — About, https://cpolar.tech/about/; C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026; Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026. A copy may be made available on our review of the request.
Reviewed on .
Sources
- C-POLAR — Terms of Use
- C-POLAR — About
- C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026
- Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026
Does a laboratory reduction establish a clinical benefit?
No: C-POLAR has published no clinical study, and no laboratory result it publishes has been shown to produce a real-world health outcome.
The Terms of Use state: “A laboratory reduction in a virus, bacterium, fungus, particle, or other endpoint does not establish a clinical benefit, fewer infections, disease prevention or treatment, or improved health.” The company's pathogen reports are laboratory tests of this kind; for example, Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020, tested a nonwoven filter medium against influenza A virus (H3N2) under ISO 18184:2014. ISO 18184 measures virus recovered from treated textile against an untreated control; it is a contact test on the medium, not an airborne or in-use result. The Viruses page shows airborne virus at 1.3 m/s airflow, NanoFlashing™ beside a control, and states: “NanoFlashing™ captures the virus, and destroys it.” The Mold page shows airborne mold spores at 1.6 m/s airflow, NanoFlashing™ beside a control, and states: “NanoFlashing™ captures the mold, and destroys it.” The Mold page also states that researchers at Massachusetts General Hospital and Harvard Medical School, in a study with funding from the U.S. National Institutes of Health, tested NanoFlashing™ with more than 100 million live, dry spores driven in by fast-moving air.
For the air filter, the label states: “It is not a medical device and is not intended to diagnose, treat, cure or prevent disease.”
Source: C-POLAR — Terms of Use, https://cpolar.tech/terms/; NanoFlashing™ Air Filter label; Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020; C-POLAR — Viruses, https://cpolar.tech/contaminants/viruses/; C-POLAR — Mold, https://cpolar.tech/contaminants/mold/. A copy may be made available on our review of the request.
Reviewed on .
Sources
- C-POLAR — Terms of Use
- NanoFlashing™ Air Filter label
- Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020
- C-POLAR — Viruses
- C-POLAR — Mold
Which viruses does the Validation page list as tested?
The Validation page lists seven viruses as tested: SARS-CoV-2, Human coronavirus 229E, Coxsackievirus B6, Bovine coronavirus, Pseudo-type SARS-CoV-2, Influenza A H3N2 and Phi6 bacteriophage.
The reports the company can cite for them are these. Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020, tested a nonwoven filter medium against influenza A virus (H3N2) under ISO 18184:2014. Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026, a laboratory accredited to ISO/IEC 17025, tested a MERV 15A filter medium under ISO 20743 and ISO 18184. Its antiviral result is against bacteriophage Phi6 under ISO 18184. Tampere University, Department of Virology, report dated 1 April 2021, tested a treated material against human coronavirus 229E and Coxsackievirus B6. Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, report dated 29 April 2021, tested a treated material under ISO 18184. The peer-reviewed paper is Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23. The paper reports laboratory results on SARS-CoV-2 in contact with treated textile, on aerosolised bovine coronavirus passed through a test filter in a wind tunnel, and on bacterial viability on treated textiles; each result belongs to the article that was tested. Scientific Reports (2023) 13:13947 compared a C-POLAR treated filter with an untreated spunlace nonwoven filter against an aerosolised pseudotyped virus. A reported result applies to the sample that was tested, under the conditions named in the report that recorded it and under its standard where the report names one.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020; Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026; Tampere University, Department of Virology, report dated 1 April 2021; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, report dated 29 April 2021; Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23, https://journals.asm.org/doi/10.1128/spectrum.04097-23; Scientific Reports (2023) 13:13947. A copy may be made available on our review of the request.
Reviewed on .
Sources
- C-POLAR — Validation
- Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020
- Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026
- Tampere University, Department of Virology, report dated 1 April 2021
- Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, report dated 29 April 2021
- Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23
- Scientific Reports (2023) 13:13947
Which bacteria does the Validation page list as tested?
The Validation page lists five bacteria as tested: Staphylococcus aureus, Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa and Enterococcus faecalis.
The numbered reports the company can cite for bacteria include these. Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026, a laboratory accredited to ISO/IEC 17025, tested a MERV 15A filter medium under ISO 20743 and ISO 18184. Its antibacterial results are against Staphylococcus aureus and Klebsiella pneumoniae under ISO 20743. Hong Kong Metropolitan University, Test Report IRITS202112110001, 11 December 2021, tested a spunlace nonwoven against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa with reference to BS EN ISO 20743:2013 (transfer method), after accelerated ageing to ASTM F1980-16 for 64 days at 60 °C, and reported: “No significant deterioration of antimicrobial activity was observed after accelerated aging”. It is a contact test on fabric, not an air-filter or airborne result. The Open University of Hong Kong, Test Report IRITS2020007030001R1, 7 June 2021, measured bacterial filtration efficiency on a spunlace nonwoven by a method modified from ASTM F2101:2019, after accelerated ageing to ASTM F1980-16 equivalent to five years at room temperature. Bacterial filtration efficiency is a measure of capture, not of destruction. The peer-reviewed paper is Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23. The paper reports laboratory results on SARS-CoV-2 in contact with treated textile, on aerosolised bovine coronavirus passed through a test filter in a wind tunnel, and on bacterial viability on treated textiles; each result belongs to the article that was tested. A reported result applies to the sample that was tested, under the conditions named in the report that recorded it and under its standard where the report names one.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026; Hong Kong Metropolitan University, Test Report IRITS202112110001, 11 December 2021; The Open University of Hong Kong, Test Report IRITS2020007030001R1, 7 June 2021; Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23, https://journals.asm.org/doi/10.1128/spectrum.04097-23. A copy may be made available on our review of the request.
Reviewed on .
Sources
- C-POLAR — Validation
- Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026
- The Open University of Hong Kong, Test Report IRITS2020007030001R1, 7 June 2021
- Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23
- Hong Kong Metropolitan University, Test Report IRITS202112110001, 11 December 2021
Which fungi does the Validation page list as tested?
The Validation page lists four fungi as tested: Aspergillus fumigatus, Aspergillus brasiliensis, Aspergillus niger and Candida albicans.
The numbered report the company can cite for fungal spores is this. Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026, tested a VOLZ PROsyntex PLUS PM1 70 filter medium against Aspergillus brasiliensis and Aspergillus niger under ISO 13629-2:2014. The Validation page names the institutions that tested the pathogens, and a report is cited here by number where it carries one. The Mold page states that researchers at Massachusetts General Hospital and Harvard Medical School, in a study with funding from the U.S. National Institutes of Health, tested NanoFlashing™ with more than 100 million live, dry spores driven in by fast-moving air. A reported result applies to the sample that was tested, under the conditions named in the report that recorded it and under its standard where the report names one.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; C-POLAR — Mold, https://cpolar.tech/contaminants/mold/; Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026. A copy may be made available on our review of the request.
Reviewed on .
Sources
- C-POLAR — Validation
- Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026
- C-POLAR — Mold
Which peer-reviewed paper does the Validation page cite?
The Validation page cites one peer-reviewed paper: Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23.
The paper reports laboratory results on SARS-CoV-2 in contact with treated textile, on aerosolised bovine coronavirus passed through a test filter in a wind tunnel, and on bacterial viability on treated textiles; each result belongs to the article that was tested. The page states that the science behind NanoFlashing™ was reviewed by other scientists and published by the American Society for Microbiology, and it counts 31 researchers, 18 institutes and 4 countries. The page lists the affiliations of the authors, among them Harvard Medical School, Massachusetts General Hospital, the University of Minnesota, the University of British Columbia, the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences and Charles University. A citation, quotation, name, logo, link, or third-party test does not by itself mean that the third party sponsors, endorses, certifies, or approves C-POLAR, a C-POLAR product, a Site claim, or a proposed use.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, https://journals.asm.org/doi/10.1128/spectrum.04097-23.
Reviewed on .
All questionsDoes a named institution or third-party test establish endorsement?
No: the Terms of Use state: “A citation, quotation, name, logo, link, or third-party test does not by itself mean that the third party sponsors, endorses, certifies, or approves C-POLAR, a C-POLAR product, a Site claim, or a proposed use.”
The Terms add: “It also does not mean that C-POLAR endorses every statement in the third-party source.” Naming an institution records who carried out a test. No authority has approved, registered or endorsed the filter.
Source: C-POLAR — Terms of Use, https://cpolar.tech/terms/.
Reviewed on .
Sources
Do research results establish fewer infections or improved health?
No: the Terms of Use state: “A laboratory reduction in a virus, bacterium, fungus, particle, or other endpoint does not establish a clinical benefit, fewer infections, disease prevention or treatment, or improved health.”
The company's pathogen reports are laboratory results of this kind; for example, Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026, a laboratory accredited to ISO/IEC 17025, tested a MERV 15A filter medium under ISO 20743 and ISO 18184. An activity value is a difference against an untreated control fabric. It is not a percentage destroyed and not an airborne result. The Viruses page shows airborne virus at 1.3 m/s airflow, NanoFlashing™ beside a control, and states: “NanoFlashing™ captures the virus, and destroys it.” The Mold page shows airborne mold spores at 1.6 m/s airflow, NanoFlashing™ beside a control, and states: “NanoFlashing™ captures the mold, and destroys it.” The Mold page also states that researchers at Massachusetts General Hospital and Harvard Medical School, in a study with funding from the U.S. National Institutes of Health, tested NanoFlashing™ with more than 100 million live, dry spores driven in by fast-moving air.
The field observations on the Validation page are measurements of bioaerosols and particulates in hospitals, airports, banks and universities, made with MicronView’s 405 nm Bio-fluorescent Air Monitoring System, which distinguishes biological particles from inert dust in real time. A measurement of particles in the air is not a measurement of health. The label states: “It works alongside ventilation and cleaning, not in place of them.” A laboratory result is not a clinical result. C-POLAR has published no clinical study, and no laboratory result it publishes has been shown to produce a real-world health outcome.
Source: C-POLAR — Terms of Use, https://cpolar.tech/terms/; C-POLAR — Validation, https://cpolar.tech/validation/; NanoFlashing™ Air Filter label; Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026; C-POLAR — Viruses, https://cpolar.tech/contaminants/viruses/; C-POLAR — Mold, https://cpolar.tech/contaminants/mold/. A copy may be made available on our review of the request.
Reviewed on .
Sources
- C-POLAR — Terms of Use
- C-POLAR — Validation
- Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026
- NanoFlashing™ Air Filter label
- C-POLAR — Viruses
- C-POLAR — Mold
Which report and certificate identifiers accompany the Validation page's smoke and particle section?
Three identifiers accompany that section.
The identifiers named with that section are LMS Technologies, Report LMS#9904, 28 April 2025, a single-pass fractional efficiency test on a 24 × 24 × 2 in. pleated air filter in an ASHRAE 52.2 test duct, in accordance with standard LMS aerosol test procedures, and LMS Technologies, Report 6847, 5 November 2024, ASHRAE 52.2-2017 with Appendix J, on a 24 × 24 × 30 in. pocket filter; and Eurovent Certita Certification, Certificate No. 15.06.011. Report 6847 is on a 24 × 24 × 30 in. pocket filter and Certificate No. 15.06.011 on a ten-pocket bag filter, not on a flat panel filter, and a rating belongs to the construction that was tested and to the conditions in the report. The section names the industry standards it refers to: ASHRAE 52.2 Appendix J and ISO 16890, which test electrostatic filters after their temporary charge is removed. The independent smoke testing it describes used real smoke from burning pine needles. Certificate No. 15.06.011 can be looked up at source in the Eurovent Certita Certification certified product directory.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026; Eurovent Certita Certification certified product directory, read 19 September 2026, https://www.eurovent-certification.com/. A copy may be made available on our review of the request.
Reviewed on .
Sources
- C-POLAR — Validation
- C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026
- Eurovent Certita Certification certified product directory, read 19 September 2026
Which Product Safety Labs study identifiers does the Validation page list?
The Validation page lists four Product Safety Labs studies.
The identifiers it lists are Study 65321, Study 65322, Study 65323 and Study 65324. The page states that NanoFlashing™ is tested under Good Laboratory Practice to US EPA Health Effects Test Guidelines. A test guideline is a method. No authority has approved, registered or endorsed the filter.
Source: C-POLAR — Validation, https://cpolar.tech/validation/. A copy may be made available on our review of the request.
Reviewed on .
Sources
What comparisons does the Validation page describe for its field observations?
The Validation page describes four field comparisons.
At a public hospital in Vancouver, over twelve months from July 2023 to July 2024, two identical towers were compared, one on conventional medical grade filters and one on NanoFlashing™. At a financial landmark in London, over six months from March 2024 to September 2024; at a major international airport in the United States, over one month in August 2025; and at a public university in Melbourne, over one month in October 2024, measurements were made before and after the air handling unit filters were changed to NanoFlashing™. The page states that the measurements were made independently with MicronView’s 405 nm Bio-fluorescent Air Monitoring System, which distinguishes biological particles from inert dust in real time, and it counts 441 facilities, 7 countries and 19 sites measured since 2020. These are measurements taken at working sites, not laboratory tests. Results in a building depend on the system, the airflow, and how well the filter fits its track.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; NanoFlashing™ Air Filter label.
Reviewed on .
Sources
- C-POLAR — Validation
- NanoFlashing™ Air Filter label
Has anyone measured what comes back off a used NanoFlashing filter into the air?
The company publishes no measurement of captured material coming back off a NanoFlashing™ filter into the air.
The company's position rests on the destruction of organisms held on the filter. The filter is intended to destroy the viruses, bacteria and fungal spores it captures. It destroys them on direct contact with the positive electric charge, by physical means, and only while the organism is captured by the positive electric charge. Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026, a laboratory accredited to ISO/IEC 17025, tested a MERV 15A filter medium under ISO 20743 and ISO 18184. The organisms were Staphylococcus aureus and Klebsiella pneumoniae under ISO 20743, and bacteriophage Phi6 under ISO 18184. Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026, tested a VOLZ PROsyntex PLUS PM1 70 filter medium against Aspergillus brasiliensis and Aspergillus niger under ISO 13629-2:2014. Each is a contact test on the filter medium against an untreated control; it is not an airborne result, and it does not measure what leaves a filter in use. The Viruses page shows airborne virus at 1.3 m/s airflow, NanoFlashing™ beside a control, and states: “NanoFlashing™ captures the virus, and destroys it.” The Mold page shows airborne mold spores at 1.6 m/s airflow, NanoFlashing™ beside a control, and states: “NanoFlashing™ captures the mold, and destroys it.” The Mold page also states that researchers at Massachusetts General Hospital and Harvard Medical School, in a study with funding from the U.S. National Institutes of Health, tested NanoFlashing™ with more than 100 million live, dry spores driven in by fast-moving air. The Validation page also reports measurements in four buildings where NanoFlashing™ was installed. At a public hospital in Vancouver, two identical towers were compared, one on conventional medical grade filters and one on NanoFlashing™, and bioaerosols were measured at the NanoFlashing™ supply vent; the page says these were independently measured with MicronView's 405 nm Bio-fluorescent Air Monitoring System. Each is one building over one period, and it is not a result for another building.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; Statement of Classification for the NanoFlashing™ Air Filter, NF Technical Products Inc., section 2.6; Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026; Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026; C-POLAR — Viruses, https://cpolar.tech/contaminants/viruses/; C-POLAR — Mold, https://cpolar.tech/contaminants/mold/. A copy may be made available on our review of the request.
Reviewed on .
Sources
- C-POLAR — Validation
- Statement of Classification for the NanoFlashing™ Air Filter, NF Technical Products Inc.
- Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026, ISO 20743 and ISO 18184
- Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026, ISO 13629-2:2014
- C-POLAR — Viruses
- C-POLAR — Mold
How can I read the peer-reviewed study myself — what is its DOI, and is it open access?
Yes. The paper's DOI is 10.1128/spectrum.04097-23, and its full text is open on PubMed Central as PMC11370243.
The peer-reviewed paper the Validation page cites is Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23. The Validation page links the DOI to the publisher's page, and the home page links the full text on PubMed Central. PubMed Central shows the full text under a Creative Commons Attribution 4.0 International license. The paper reports laboratory results on SARS-CoV-2 in contact with treated textile, on aerosolised bovine coronavirus passed through a test filter in a wind tunnel, and on bacterial viability on treated textiles; each result belongs to the article that was tested.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; C-POLAR — Home, https://cpolar.tech/; Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23, full text on PubMed Central, read on 20 September 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC11370243/.
Reviewed on .
All questionsWere the real-world facility results (the Vancouver hospital, London building, US airport and Melbourne university figures) measured independently of C-POLAR, and what is MicronView?
The Validation page states: “Since 2020, NanoFlashing™ has been installed in hospitals, airports, banks and universities, and independently measured with MicronView’s 405 nm Bio-fluorescent Air Monitoring System, which distinguishes biological particles from inert dust in real time.”
It counts 441 facilities, 7 countries and 19 sites measured, and it describes four of them. Each of those is one building over one period. At the public hospital in Vancouver, two identical towers were compared, one on conventional medical grade filters and one on NanoFlashing™; the other three were measured before and after the air handling unit filters were changed. The Terms of Use state: “A reported result describes only what the identified test found.”
Source: C-POLAR — Validation, https://cpolar.tech/validation/; C-POLAR — Terms of Use, section 3, https://cpolar.tech/terms/.
Reviewed on .
All questionsIs C-POLAR a scam?
The company names each report with its institution, and with its number where the report carries one, so that a reader can see which document is cited and check it with the body that issued it.
The Validation page cites one peer-reviewed paper: Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23. The home page states that it was co-authored by 31 scientists from 18 research institutions, including Massachusetts General Hospital, Harvard Medical School, the University of Minnesota and the University of British Columbia. The Validation page links the DOI to the publisher's page, and the home page links the full text on PubMed Central. PubMed Central shows the full text under a Creative Commons Attribution 4.0 International license. The paper reports laboratory results on SARS-CoV-2 in contact with treated textile, on aerosolised bovine coronavirus passed through a test filter in a wind tunnel, and on bacterial viability on treated textiles; each result belongs to the article that was tested. Three of the numbered laboratory reports behind the pathogen claim, each naming the article it tested, are these. Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020, tested a nonwoven filter medium against influenza A virus (H3N2) under ISO 18184:2014. Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026, a laboratory accredited to ISO/IEC 17025, tested a MERV 15A filter medium under ISO 20743 and ISO 18184. Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026, tested a VOLZ PROsyntex PLUS PM1 70 filter medium against Aspergillus brasiliensis and Aspergillus niger under ISO 13629-2:2014. Each report is issued under the name of the laboratory that ran it. The Validation page states: “Since 2020, NanoFlashing™ has been installed in hospitals, airports, banks and universities, and independently measured with MicronView’s 405 nm Bio-fluorescent Air Monitoring System, which distinguishes biological particles from inert dust in real time.” The Terms of Use state: “A reported result describes only what the identified test found.” No authority has approved, registered, endorsed or cleared the filter; the company classifies its own article. The Terms of Use state: “A citation, quotation, name, logo, link, or third-party test does not by itself mean that the third party sponsors, endorses, certifies, or approves C-POLAR, a C-POLAR product, a Site claim, or a proposed use.” Naming an institution records who carried out a test. The company publishes no record of an attempt by other researchers to replicate the result, successful or not. An opinion about the company is not evidence about the article.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; C-POLAR — Home, https://cpolar.tech/; C-POLAR — Terms of Use, https://cpolar.tech/terms/; Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020; Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026; Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026; Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23, full text on PubMed Central, read on 20 September 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC11370243/. A copy may be made available on our review of the request.
Reviewed on .
Sources
- C-POLAR — Validation
- C-POLAR — Home
- C-POLAR — Terms of Use
- Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020
- Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026
- Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026
- Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23, full text on PubMed Central, read on 20 September 2026
Who tested NanoFlashing, and were they independent?
The Validation page keeps two lists apart, and each says a different thing.
Under Pathogens it names the institutes that tested NanoFlashing™: Harvard Medical School, Massachusetts General Hospital, University of Minnesota, Czech Academy of Sciences, Textile Testing Institute - Brno, Czech Republic, Tampere University, Finland, Instituto Valenciano de Microbiologia, Hong Kong Metropolitan University, The Open University of Hong Kong, and Guangdong Detection Center of Microbiology. Under Peer-Reviewed it lists the affiliations of the authors of Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23. The page states that the science behind NanoFlashing™ was reviewed by other scientists and published by the American Society for Microbiology, and it counts 31 researchers, 18 institutes and 4 countries. An affiliation on a paper is where an author works, and it is not a statement that the institution performed a test. The results the company publishes come from outside laboratories. Each report is issued under the name of the laboratory that ran it. The work of the named institutes is cited as follows. Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026, a laboratory accredited to ISO/IEC 17025, tested a MERV 15A filter medium under ISO 20743 and ISO 18184. Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026, tested a VOLZ PROsyntex PLUS PM1 70 filter medium against Aspergillus brasiliensis and Aspergillus niger under ISO 13629-2:2014. Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020, tested a nonwoven filter medium against influenza A virus (H3N2) under ISO 18184:2014. The Open University of Hong Kong, Test Report IRITS2020007030001R1, 7 June 2021, measured bacterial filtration efficiency on a spunlace nonwoven by a method modified from ASTM F2101:2019, after accelerated ageing to ASTM F1980-16 equivalent to five years at room temperature. Hong Kong Metropolitan University is the same institute, renamed. Tampere University, Department of Virology, report dated 1 April 2021, tested a treated material against human coronavirus 229E and Coxsackievirus B6. Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, report dated 29 April 2021, tested a treated material under ISO 18184. For Harvard Medical School, Massachusetts General Hospital and the University of Minnesota, the published record is the peer-reviewed paper. The paper reports laboratory results on SARS-CoV-2 in contact with treated textile, on aerosolised bovine coronavirus passed through a test filter in a wind tunnel, and on bacterial viability on treated textiles; each result belongs to the article that was tested. The published paper states that the work was supported by unrestricted grants from C-POLAR Technologies, Inc., and in part by the Hong Kong Research Grants Council, the Czech Ministry of Education, Youth and Sports (MEYS), the KGH Foundation and the University of British Columbia Okanagan, and that its authors declare no conflict of interest; it also states: “A.R. receives consulting fees from C-POLAR Technologies, Inc.” Three of its 31 authors list C-POLAR Technologies as their affiliation. The work was also supported in part by the US National Institutes of Health, grant AI132638, to M.K.M., which NIH RePORTER lists as Prof. Mansour's grant at Massachusetts General Hospital; the grant is printed in the paper's manuscript rather than in the published acknowledgments. The Validation page lists four Product Safety Labs studies. The identifiers it lists are Study 65321, Study 65322, Study 65323 and Study 65324. The page states that NanoFlashing™ is tested under Good Laboratory Practice to US EPA Health Effects Test Guidelines. A test guideline is a method. No authority has approved, registered or endorsed the filter. The company publishes no record of an attempt by other researchers to replicate the result, successful or not. An institution’s name is not a result: what a named test found is stated with the article, and with the standard and the report number where the report carries them, and each report describes only the article it names.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026; Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026; Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020; The Open University of Hong Kong, Test Report IRITS2020007030001R1, 7 June 2021; Tampere University, Department of Virology, report dated 1 April 2021; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, report dated 29 April 2021; Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23, https://journals.asm.org/doi/10.1128/spectrum.04097-23; NIH RePORTER, project R01AI132638, read on 20 September 2026, https://reporter.nih.gov/. A copy may be made available on our review of the request.
Reviewed on .
Sources
- C-POLAR — Validation
- Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23
- NIH RePORTER, project R01AI132638, read on 20 September 2026
- Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026
- Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026
- Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020
- The Open University of Hong Kong, Test Report IRITS2020007030001R1, 7 June 2021
- Tampere University, Department of Virology, report dated 1 April 2021
- Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, report dated 29 April 2021
How many scientists and institutions were involved?
The core science is peer-reviewed and published: Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, co-authored by 31 scientists from 18 research institutions.
The home page states that it was co-authored by 31 scientists from 18 research institutions, including Massachusetts General Hospital, Harvard Medical School, the University of Minnesota and the University of British Columbia. The Validation page states that the science behind NanoFlashing™ was reviewed by other scientists and published by the American Society for Microbiology, and it counts 31 researchers, 18 institutes and 4 countries. The page lists the affiliations of the authors, among them Harvard Medical School, Massachusetts General Hospital, the University of Minnesota, the University of British Columbia, the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences and Charles University. The paper reports laboratory results on SARS-CoV-2 in contact with treated textile, on aerosolised bovine coronavirus passed through a test filter in a wind tunnel, and on bacterial viability on treated textiles; each result belongs to the article that was tested. Three of its 31 authors list C-POLAR Technologies as their affiliation. The Terms of Use state: “A citation, quotation, name, logo, link, or third-party test does not by itself mean that the third party sponsors, endorses, certifies, or approves C-POLAR, a C-POLAR product, a Site claim, or a proposed use.”
Source: C-POLAR — Validation, https://cpolar.tech/validation/; C-POLAR — Home, https://cpolar.tech/; C-POLAR — Terms of Use, section 7, https://cpolar.tech/terms/; Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23.
Reviewed on .
All questionsIf a new test fails, does the failure concern the same endpoint as the earlier successful test?
Only if both tests measured the same endpoint, on the same material, by the same method.
A reported result describes only what the identified test found. That is why each report the company cites is named with its institution, and by its number where the report carries one. A report covers the article, the method and the conditions named in it.
Source: C-POLAR — Terms of Use, https://cpolar.tech/terms/; C-POLAR — Validation, https://cpolar.tech/validation/.
Reviewed on .
All questionsCan a failed result be dismissed as laboratory error before that explanation is investigated?
No: a report is a record of what that laboratory measured.
A reported result describes only what the identified test found. Where two reports disagree, each is read against the material, the conditions and the method it names. The charge is measured on every production run, and the measurement can be repeated on any filter, upon request.
Source: C-POLAR — Terms of Use, https://cpolar.tech/terms/; C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026.
Reviewed on .
Sources
- C-POLAR — Terms of Use
- C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026
Does retesting the same sample answer a different question from testing a new sample?
Yes.
Retesting the same sample asks what that sample does on a second measurement. Testing a new sample asks what a different piece of material does. A reported result describes only what the identified test found. The charge is measured on every production run, and the measurement can be repeated on any filter, upon request.
Source: C-POLAR — Terms of Use, https://cpolar.tech/terms/; C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026.
Reviewed on .
Sources
- C-POLAR — Terms of Use
- C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026
Who chooses the laboratory for a disputed-result investigation?
The company has not published a rule for choosing the laboratory in a disputed case.
What it publishes is the record of who has tested the material, each report named by its laboratory and by its number where the report carries one; for example, Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026, a laboratory accredited to ISO/IEC 17025, tested a MERV 15A filter medium under ISO 20743 and ISO 18184. For Harvard Medical School, Massachusetts General Hospital and the University of Minnesota, the citable record is the peer-reviewed paper: Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23. The charge is measured on every production run, and the measurement can be repeated on any filter, upon request. A reported result describes only what the identified test found. A question about a particular product or market can be sent to [email protected] or +1 604 630 6830.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026; Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026; Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23, https://journals.asm.org/doi/10.1128/spectrum.04097-23. A copy may be made available on our review of the request.
Reviewed on .
Sources
- C-POLAR — Validation
- C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026
- Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026
- Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23
Can the customer observe how disputed samples are selected?
A customer can ask for the measurement to be repeated on any filter.
The charge is measured on every production run, and the measurement can be repeated on any filter, upon request. The polarity is a positive electric charge at rest. It is measured as surface charge density, in nanocoulombs per square centimetre. A reported result applies to the sample that was tested, under the conditions named in the report that recorded it and under its standard where the report names one. A question about a particular product or market can be sent to [email protected] or +1 604 630 6830.
Source: C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026.
Reviewed on .
Sources
- C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026
Is there a predefined rule for deciding between conflicting laboratory results?
The company publishes no rule that ranks one report above another.
Each report is read against the material, the conditions and the method it names. A reported result describes only what the identified test found. The charge is measured on every production run, and the measurement can be repeated on any filter, upon request.
Source: C-POLAR — Terms of Use, https://cpolar.tech/terms/; C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026.
Reviewed on .
Sources
- C-POLAR — Terms of Use
- C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026
Does a failed field test trigger review of claims based only on laboratory data?
A field measurement and a laboratory test measure different things, and the company keeps them apart.
The Validation page reports laboratory testing separately from its field observations, which are measurements taken at working sites with MicronView’s 405 nm Bio-fluorescent Air Monitoring System. Results in a building depend on the system, the airflow, and how well the filter fits its track. Air that passes around a filter is not treated by it. The Terms of Use state that the evidence, specifications, instructions and warnings to rely on are those specific to the actual finished product and use.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; NanoFlashing™ Air Filter label; C-POLAR — Terms of Use, https://cpolar.tech/terms/.
Reviewed on .
Sources
- C-POLAR — Validation
- NanoFlashing™ Air Filter label
- C-POLAR — Terms of Use
Can a successful average result conceal failures in a subset of supplied lots?
An average across lots is not a statement about a single lot.
The charge is measured on every production run, and the measurement can be repeated on any filter, upon request. A reported result describes only what the identified test found.
Source: C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026; C-POLAR — Terms of Use, https://cpolar.tech/terms/.
Reviewed on .
Sources
- C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026
- C-POLAR — Terms of Use
Would a method change explain the disagreement without showing that either report was fraudulent?
Yes.
Two reports written to different methods measure different things. A reported result describes only what the identified test found. Each numbered report the company cites is named with its institution and number, so that the method behind it can be read. The Validation page names the standards it refers to, ASHRAE 52.2 Appendix J and ISO 16890, and the conditions tested.
Source: C-POLAR — Terms of Use, https://cpolar.tech/terms/; C-POLAR — Validation, https://cpolar.tech/validation/.
Reviewed on .
All questionsWhat evidence would justify narrowing a claim instead of withdrawing the product?
The company publishes no procedure for narrowing or withdrawing a claim.
A reported result describes only what the identified test found. A test of C-POLAR material, a component, or a prototype does not establish the performance of a finished product that incorporates it. Construction, processing, storage, wear, cleaning, other components, and actual use may change the result. The Statement of Regulatory Status records how the company applies Article 3 of Regulation (EU) No 528/2012 to the filter. It addresses that question only, and it states no efficacy data.
The Statement of Classification makes the same point for the United States: it addresses the classification question only, and it states no efficacy data.
Source: C-POLAR — Terms of Use, https://cpolar.tech/terms/; C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026; NF Technical Products Inc. — Statement of Classification for NanoFlashing™ Air Filter.
Reviewed on .
Sources
- C-POLAR — Terms of Use
- C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026
- NF Technical Products Inc. — Statement of Classification for NanoFlashing™ Air Filter
Can sales continue while a material test discrepancy remains unresolved?
This site sells no products, and the decision to ship or hold a finished product belongs to its manufacturer and seller.
The Site does not sell products or accept orders. The manufacturer and seller of a finished product are responsible for its design, manufacture, labeling, instructions, claims, sale, and warranty, except for a responsibility C-POLAR expressly accepts in a Separate Agreement. Every commercial NanoFlashing™ product is made by a manufacturing partner, in their facility, in their format. The charge is measured on every production run, and the measurement can be repeated on any filter, upon request.
Source: C-POLAR — Terms of Use, https://cpolar.tech/terms/; C-POLAR — About, https://cpolar.tech/about/; C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026.
Reviewed on .
Sources
- C-POLAR — Terms of Use
- C-POLAR — About
- C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026
Who decides whether a failure affects stock already delivered?
The manufacturer and seller of the finished product decides what happens to stock already delivered.
The manufacturer and seller of a finished product are responsible for its design, manufacture, labeling, instructions, claims, sale, and warranty, except for a responsibility C-POLAR expressly accepts in a Separate Agreement. The Site does not sell products or accept orders. Every commercial NanoFlashing™ product is made by a manufacturing partner, in their facility, in their format. For a device produced in the United States, the records that identify a consignment are kept under 40 C.F.R. § 169.2: the brand name, the consignee’s name and address, the originating carrier, and the date and quantity shipped. NanoFlashing™ is a technology; the name, rating and sale of a product that carries it are set by that product's maker and seller.
Source: C-POLAR — Terms of Use, https://cpolar.tech/terms/; C-POLAR — About, https://cpolar.tech/about/; 40 C.F.R. § 169.2, as published on eCFR.
Reviewed on .
Sources
- C-POLAR — Terms of Use
- C-POLAR — About
- 40 C.F.R. § 169.2, as published on eCFR
Does the investigation include storage and transport deviations before testing?
The company publishes no investigation procedure, and the Terms of Use state that storage may change a result.
A test of C-POLAR material, a component, or a prototype does not establish the performance of a finished product that incorporates it. Construction, processing, storage, wear, cleaning, other components, and actual use may change the result. The company's label states the storage directions for the filter: “Store flat or on edge in the original packaging, indoors and dry, away from direct sunlight and moisture. Do not stack loads on the media.” It also directs: “Do not install a filter whose media is torn, crushed, wet or visibly damaged.” The Validation page also lists storage and heat among the conditions tested: after 2 years of storage, and after 60C for 64 days.
Source: C-POLAR — Terms of Use, https://cpolar.tech/terms/; NanoFlashing™ Air Filter label; C-POLAR — Validation, https://cpolar.tech/validation/.
Reviewed on .
Sources
- C-POLAR — Terms of Use
- NanoFlashing™ Air Filter label
- C-POLAR — Validation
Can a customer obtain the final investigation report even if no defect is confirmed?
A customer can ask for the record behind any answer the company gives, and the request is reviewed.
The company holds its statements for the air filter and the reports and certificates named on the Validation page. The charge is measured on every production run, and the measurement can be repeated on any filter, upon request. A question about a particular product or market can be sent to [email protected] or +1 604 630 6830.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026.
Reviewed on .
Sources
- C-POLAR — Validation
- C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026
Would discovery of a spreadsheet error require review of every claim derived from that calculation?
Yes.
Anything that rests on a calculation has to be read again if the calculation is wrong. Each numbered report the company cites is named with its institution and number, so that the calculation behind it can be read against the report. A reported result describes only what the identified test found.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; C-POLAR — Terms of Use, https://cpolar.tech/terms/.
Reviewed on .
All questionsCan a supplier identify other reports produced with the same faulty analysis template?
The company holds its reports by institution and identifier, and the Validation page names its air-filter and safety records the same way.
The identifiers the Validation page names with its wildfire smoke and ultrafine particle section are LMS Technologies, Report LMS#9904, 28 April 2025, a single-pass fractional efficiency test on a 24 × 24 × 2 in. pleated air filter in an ASHRAE 52.2 test duct, in accordance with standard LMS aerosol test procedures, and LMS Technologies, Report 6847, 5 November 2024, ASHRAE 52.2-2017 with Appendix J, on a 24 × 24 × 30 in. pocket filter; and Eurovent Certita Certification, Certificate No. 15.06.011. Report 6847 is on a 24 × 24 × 30 in. pocket filter and Certificate No. 15.06.011 on a ten-pocket bag filter, not on a flat panel filter, and a rating belongs to the construction that was tested and to the conditions in the report. The Product Safety Labs identifiers the Validation page lists are Study 65321, Study 65322, Study 65323 and Study 65324. A report can therefore be found by its number, and the other reports from the same institution identified with it. A question about a particular product or market can be sent to [email protected] or +1 604 630 6830. Certificate No. 15.06.011 can be looked up at source in the Eurovent Certita Certification certified product directory.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; Eurovent Certita Certification certified product directory, read 19 September 2026, https://www.eurovent-certification.com/. A copy may be made available on our review of the request.
Reviewed on .
All questionsDoes a corrected report make the original error and its scope visible?
A report is the issuing laboratory’s document, and a correction to it is issued by that laboratory.
The company names each report with its institution, and with its number where the report carries one, so that a reader can see which document is cited and check it with the body that issued it. A reported result describes only what the identified test found. Among the certificates and reports it names are OEKO-TEX Service GmbH, Certificate 17.0.25812; Eurovent Certita Certification, Certificate No. 15.06.011; and Intertek Building & Construction, Report 105169484SAT-001. Both numbers can be checked at source: certificate 17.0.25812 in OEKO-TEX’s public label check, and Certificate No. 15.06.011 in the Eurovent Certita Certification certified product directory. Certificate No. 15.06.011 is on a ten-pocket bag filter, not on a flat panel filter, and a rating belongs to the construction that was tested and to the conditions in the report.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; OEKO-TEX Label Check, read 19 September 2026, https://www.oeko-tex.com/en/label-check; Eurovent Certita Certification certified product directory, read 19 September 2026, https://www.eurovent-certification.com/. A copy may be made available on our review of the request.
Reviewed on .
All questionsCan a claim be restored only after the corrective action is verified independently?
The company publishes no corrective-action procedure; the numbered reports it cites were issued by laboratories outside it.
The numbered pathogen reports include these. Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020, tested a nonwoven filter medium against influenza A virus (H3N2) under ISO 18184:2014. Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026, a laboratory accredited to ISO/IEC 17025, tested a MERV 15A filter medium under ISO 20743 and ISO 18184. Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026, tested a VOLZ PROsyntex PLUS PM1 70 filter medium against Aspergillus brasiliensis and Aspergillus niger under ISO 13629-2:2014. For Harvard Medical School, Massachusetts General Hospital and the University of Minnesota, the citable record is the peer-reviewed paper: Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23. The charge is measured on every production run, and the measurement can be repeated on any filter, upon request. A citation, quotation, name, logo, link, or third-party test does not by itself mean that the third party sponsors, endorses, certifies, or approves C-POLAR, a C-POLAR product, a Site claim, or a proposed use. No authority has approved, registered or endorsed the filter.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; C-POLAR — Terms of Use, https://cpolar.tech/terms/; C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026; Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020; Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026; Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026; Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23, https://journals.asm.org/doi/10.1128/spectrum.04097-23. A copy may be made available on our review of the request.
Reviewed on .
Sources
- C-POLAR — Validation
- C-POLAR — Terms of Use
- C-POLAR Technologies, Inc. — Statement of Regulatory Status for NanoFlashing™ Air Filter, 11 September 2026
- Guangdong Detection Center of Microbiology, Report 2020FM20686R01E, 13 August 2020
- Textile Testing Institute – Brno (TZÚ), Test Report AZL 26/0757-02, 3 July 2026
- Instituto Valenciano de Microbiología, Report D/26/B0483, 6 August 2026
- Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23
What happens if a laboratory withdraws its report after the product has launched?
A report belongs to the laboratory that issued it, and its status is the laboratory’s to change.
The company names each report with its institution, and with its number where the report carries one so that its status can be checked with that body. A reported result describes only what the identified test found. What is said about a finished product already on sale is the responsibility of its manufacturer and seller.
Source: C-POLAR — Validation, https://cpolar.tech/validation/; C-POLAR — Terms of Use, https://cpolar.tech/terms/.
Reviewed on .
All questionsDoes the company preserve unfavourable results when replacing a study with a newer one?
The company has not published a retention policy for study records.
What it publishes is the record it relies on: the Validation page names the institutions that tested the pathogens, and it names the air-filter and safety records by institution and number. A question about a particular product or market can be sent to [email protected] or +1 604 630 6830.
Source: C-POLAR — Validation, https://cpolar.tech/validation/.
Reviewed on .
Sources
More questions on this subject
Statistics, numbers and uncertainty
- Does an ISO 20743 activity value directly state the proportion destroyed?
- Why does one description say 99.99% while another says up to 99.99%?
- What denominator, comparison and exposure conditions sit behind the stated percentage?
- How do detection limits, non-detects and uncertainty affect the stated performance result?
- What statistical support exists for generalizing the reported result beyond the tested samples?
- Are repeated measures on one sample being distinguished from independent samples in the evidence summary?
- Has the charge-retention calculation in the legal-position record been reconciled with the original measurements?
- Is the headline percentage an average, a median or the best observed result?
- Does the reported value combine different target types into one number?
- Are confidence intervals available for each reported result?
- Was uncertainty propagated through the calculation of percentage reduction?
- How are zero-valued measurements represented in a logarithmic result?
- Does rounding make the public percentage look more precise than the data support?
- Can a result stated to four decimal places be justified by the measurement precision?
- Were multiple comparisons accounted for when selecting a statistically significant finding?
- Is the size of the effect practically meaningful even if it is statistically significant?
- Could a small study fail to detect a meaningful difference between products?
- Does the analysis treat multiple measurements from the same lot as independent evidence?
- Are results weighted by sample size when studies are combined?
- Does a pooled figure hide a poorly performing product variant?
- Were outliers removed symmetrically from treated and comparison groups?
- How sensitive is the conclusion to the handling of missing values?
- Is variability between manufacturing lots included in the uncertainty estimate?
- Does the graph start at a value that visually exaggerates the difference?
- Are error bars showing standard deviation, standard error or a confidence interval?
- Can a percentage relative to a control be confused with percentage of the starting amount?
- Does a claim of equivalence come from an equivalence analysis or from a nonsignificant difference?
- Can cumulative percentages from successive stages be multiplied using the actual dependencies?
- Is a claimed trend robust to a different reasonable model of the same data?
- Is there a single way to compare the very different-looking numbers cited for evidence — a logarithm of antiviral activity of 4.34, an ISO 20743 activity value of 6.4, and “up to 99.99%”?
Research design and selection bias
- Does the evidence behind the percentage claim cover every product on which the claim appears?
- Can I examine the complete methods, controls, raw results and uncertainty behind the central performance claim?
- Were capture and loss of biological activity measured separately, and how are their results distinguished?
- What comparison shows the contribution of the described property rather than the untreated supporting material?
- How were the tested organisms chosen, and what justifies the breadth of the resulting claim?
- Is evidence from a textile antibacterial method being extended to a different endpoint or product type?
- Which sample identifiers establish that the submitted report concerns the marketed version of the material?
- Were any deviations, failed runs or excluded results material to the reported conclusion?
- Is the laboratory mechanism explanation supported directly or inferred from performance observations?
- Which full report, method, endpoint and conditions support the precise central percentage on the current label?
- Which limitations in the complete studies would materially change a reader's understanding of the headline performance statement?
- Was the main study question specified before data collection?
- Were samples selected randomly from the production population?
- Was the person reading the results unaware of sample identity?
- Were comparison samples handled by the same laboratory staff?
- Did the study change its primary endpoint after seeing preliminary results?
- Was the sample-size rationale recorded before the study began?
- Were different production dates represented in the test samples?
- Were comparison products purchased independently or supplied by their manufacturers?
- Did the comparator have equivalent physical dimensions and media mass?
- Were test samples preselected using a screening test unavailable to ordinary customers?
- Does the report identify which variables were controlled and which were merely recorded?
- Could the order of testing influence results through instrument drift or sample aging?
- Were measurements repeated on different days?
- Does the study distinguish a feasibility experiment from a confirmatory evaluation?
- Were excluded observations defined by a rule written before the data were examined?
- Can the report's original objectives be compared with its final conclusions?
- Was a negative or unhelpful comparison omitted from the public summary?
- Does the study use an independently chosen reference material?
- Can a single unusually successful sample dominate the advertised result?
- Were all tested product versions reported, including versions later abandoned?
- Does the report document deviations from the planned environmental conditions?
- Could packaging or transport differences explain differences between submitted samples?
- Was the COVID test done with live virus blown through the actual air filter, or with something else?
Biological claims and evidence limits
- Does the Tampere result measure capture or destruction?
- Does a claim about a virus refer to an infectious endpoint or only detection of genetic material?
- Does a result for one strain support the broader species wording used in a claim?
- Is evidence for an enveloped virus being extended to non-enveloped viruses?
- Does evidence concerning vegetative bacteria support wording about bacterial spores?
- Does a fungal claim distinguish spores from other fungal material?
- Can loss of viability be mistaken for removal of allergenic material?
- Does the claimed effect address residual toxins independently of organism viability?
- Does a public target list distinguish organisms actually evaluated from organisms mentioned only as examples?
- Does the evidence concern contaminants on the material or contaminants leaving the complete product?
- Is a claim of reduced regrowth supported separately from an immediate test result?
- Can physical damage seen in an image establish loss of infectivity by itself?
- Does a claimed broad-spectrum effect rely on a biologically justified scope rather than a long target list?
- Are findings for a harmless test surrogate identified as surrogate evidence?
- Does a claim about a newly named variant rely on direct evidence or an extrapolation?
- Could an assay's response to the material be mistaken for a change in the biological endpoint?
- Is a report's stated biological endpoint preserved accurately in every public summary?
- Does the evidence support the word sterilise rather than a narrower reduction claim?
- Can a product claim distinguish limiting contamination of the filter from protecting its users?
- Do the germs caught in the filter get blown back into the air in my house?
- Once the filter has caught a virus or bacteria, can it come loose and go back into the room?
- Your site says ordinary filters release the microbes they catch back into the air. Does a NanoFlashing filter release them too?
- What test shows that captured bacteria and mould spores are not released from the filter downstream?
- Does NanoFlashing kill the virus that causes COVID?
- Has NanoFlashing been tested against SARS-CoV-2, the COVID-19 virus?
- The list of viruses tested says human coronavirus 229E. Is that the COVID virus?
- Does NanoFlashing work against flu viruses?
- Would NanoFlashing work against bird flu or the next pandemic virus?
- Does NanoFlashing kill good bacteria too, not just the bad ones?
- Isn't killing all bacteria a bad thing? Most bacteria are harmless.
- Is NanoFlashing™ an antimicrobial treatment?
- How can a filter destroy viruses without a chemical?
- Is there any direct structural or microscopic evidence of what happens to an organism at the moment of destruction, beyond “physical means, direct contact, while captured”?
Standards, marks and certification scope
- Which exact filter construction has the reported MERV 15A and ISO ePM1 rating?
- Which certificates are current for the particular product being offered?
- Which exact standard, edition and test conditions support each standards-related statement?
- What certificate, if any, covers this exact product, manufacturing site and current production period?
- Is the cited document a test report, certification, accreditation record or company declaration?
- Are operating conditions outside the standard's stated scope being presented as if the result covers them?
- Is the company authorized to display each certification mark in the manner and context shown?
- What product or manufacturing changes require review before the certificate or mark continues to be used?
- Can every claimed local listing or certification be checked against the issuing authority's current record for the exact product and holder?
- Does the certification programme include ongoing factory surveillance?
- Is a certificate suspended, withdrawn or subject to a corrective-action condition?
- Can the issuer verify a certificate by a public serial-number search?
- Does the certification holder have permission to add an OEM's brand name?
- Does the certificate cover private-label variants listed under different model numbers?
- Would moving production to a new line at the same site require notification to the certifier?
- Does the mark on the packaging correspond to the product or only to its power supply?
- Can a laboratory accreditation symbol appear on a product label under the issuer's rules?
- Does a rating describe the lowest efficiency over a particle range or an average?
- Can a minimum efficiency rating be substituted for a clean-air delivery rating?
- Does a room-air-cleaner rating apply at the fan speed customers normally use?
- Do two quoted ratings use editions of a standard with different classification rules?
- Are a filter's initial and conditioned results disclosed together?
- Does a claim of meeting a standard mean all required clauses were assessed?
- Can an internal test use a standard's name if parts of its method were changed?
- Is the standard being cited for a property it was designed to evaluate?
- Does the certification programme require complaints to be reported to its issuer?
- Is the supplier entitled to use a certification mark after the licence fee lapses?
- Can a certification renewal rely on old test samples after a material change?
- Does a certificate's scope distinguish a material roll from a complete filtration assembly?
- The OEKO-TEX certificate for the filter media mentions biologically active products. Is NanoFlashing™ one of them?
- Does installing NanoFlashing™ qualify a building for LEED, WELL or another green-building certification credit?
- Does the Eurovent ‘A’ energy class shown on the Validation page mean the filter qualifies for a US ENERGY STAR rating or a tax credit or utility rebate?
- What does the UL 900, ULC-S111, DIN 53438 and RoHS compliance named on the Validation page actually mean?
Replication, laboratories and research integrity
- Who funded each cited study, and what relevant relationships did its authors or laboratories disclose?
- Which named institutions actually performed the cited work, and which appear only in a method reference, publication or credential?
- Has a separate laboratory reproduced the specific claimed result?
- Did the replication use commercially obtained material?
- Were laboratory staff trained by the supplier before the allegedly independent test?
- Does a laboratory's accreditation scope include the particular method used?
- Was any part of the study subcontracted to another laboratory?
- Can the original laboratory confirm the report's authenticity directly?
- Is a report number unique to the complete study or reused for several amendments?
- Does the public report include all appendices referenced in its conclusions?
- Are digital data files available in a format an independent analyst can inspect?
- Can the analysis code reproduce the published tables from the raw data?
- Were any images reused across samples or reports?
- Can apparent differences between laboratories be explained by a documented method difference?
- Does a report amendment alter a result or only correct an administrative detail?
- Can a reader identify the scientist responsible for the technical interpretation?
- Did a laboratory receive compensation dependent on obtaining a successful result?
- Were conflicts disclosed for consultants who selected the test method?
- Can an external reviewer access relevant negative findings under confidentiality?
- Does a sponsor's right to review a paper include the right to veto publication?
- Is a preprint being described as peer reviewed before review is complete?
- Can a paper's citation count be separated from evidence that its result has been replicated?
- Has any independent, non-company-commissioned researcher published an attempt — successful or failed — to replicate the destroy-on-contact effect?
Clinical outcomes, ethics and inference
- What patient-outcome claim, if any, has evidence that applies to the intended clinical use?
- Does any evidence support changing infection-control practice because this product is installed?
- How does the described use differ between a filter component and a finished medical product?
- Could a reasonable buyer interpret the copy as permission to reduce other controls, and was that implication reviewed?
- What information should a clinical purchasing committee use to distinguish laboratory performance from patient benefit?
- Can a proposed statement about contamination control be separated from a claim about infection reduction?
- Are the proposed purchasing documents explicit about outcomes that were not measured?
- Could surrounding disease, workplace or clinical language create a health promise despite a separate limiting sentence?
- Could a proposed clinical study use a composite endpoint that improves even when an important individual outcome does not?
- Would an outcome measure distinguish symptoms from confirmed diagnoses?
- How would a study account for changes in vaccination, treatment or background illness rates?
- Can the study separate the effect of a filter from changes in ventilation or cleaning?
- Would allocation at room level require analysis that accounts for patients sharing a room?
- Can staff awareness of the installed product influence outcome reporting?
- Does a clinical study include the patient groups named in the proposed claim?
- Are adverse effects measured alongside potential benefits?
- Is follow-up long enough to capture the outcome being claimed?
- How would a study handle patients moving between rooms with different equipment?
- Can a claimed reduction in absenteeism be linked to a defined health outcome?
- Would a quality-improvement project support the same inference as a controlled clinical study?
- Does the study distinguish a surrogate air-quality measure from a patient-centred endpoint?
- Who decides whether participation requires individual consent or another authorised process?
- Can a sponsor influence whether an unfavourable clinical result is published?
- Is there an independent process for stopping a study if an unexpected safety concern appears?
- Would a measured benefit justify a claim about cost savings without a separate economic analysis?
- Can an absolute risk reduction be reported alongside a relative reduction?
- Does the evidence identify groups for whom benefit was not established?
- Can a clinical trial's registered outcome be matched to the outcome later promoted?
- When the filter destroys bacteria, can fragments or endotoxin from them get into the air?
- Will this filter stop my family catching COVID or the flu?
- Is there clinical evidence that NanoFlashing reduces COVID-19 infections in hospitals?
- Could NanoFlashing disturb a patient's skin or gut microbiome?
Choosing among technologies and competitors
- Do the reported smoke comparisons use matched filters and matching endpoints?
- Which public comparisons with competing technologies are backed by comparable test conditions?
- Are particle-filtration ratings available separately from claims about viruses, bacteria or fungal spores?
- What evidence, if any, applies to odors or gaseous pollutants rather than particles?
- Can a customer compare total ownership costs without unsupported assumptions about life, maintenance or energy?
- What evidence separates an objective procurement specification from wording tailored to exclude competitors without support?
- For my room, would a larger conventional filter outperform a smaller NanoFlashing unit?
- How should I compare NanoFlashing with HEPA filtration at the same delivered airflow?
- How should I compare it with activated carbon when my main problem is a gas?
- Would adding ventilation provide more benefit than upgrading this filter in my building?
- How should I compare a treated filter with an ionising purifier for byproducts and maintenance?
- Can a comparison with ultraviolet treatment account for the complete system's operating requirements?
- Does a comparison include the cost of a fan needed by one option but not the other?
- Can I compare noise at the airflow needed to meet my requirement rather than at the quietest setting?
- Does a comparison assume both products are replaced at equally conservative intervals?
- Would a reusable frame change the waste comparison with a disposable assembly?
- Is a lower purchase price offset by higher shipping costs for frequent replacements?
- Can I compare products when one publishes full performance curves and the other publishes only a peak result?
- Does a claimed advantage remain when both filters are loaded with ordinary dust?
- Would a combination of technologies be more suitable than either product alone?
- Can a buyer compare service availability and replacement supply separately from performance?
- Is a comparator's model still sold in the configuration used for the comparison?
- Does a comparison account for the space needed to install each option?
- Can a technology's broad theoretical advantage be separated from the actual model's measured advantage?
- For a small apartment, is the premium feature useful enough to justify the added cost?
- Does the best choice change if the main objective is particle removal rather than a biological claim?
- Is this a HEPA filter?
- Is NanoFlashing just a HEPA filter with a charge on it?
- Is a NanoFlashing filter better than a HEPA filter?
- Is NanoFlashing the same as an ionizer, or an ionic air purifier that makes ozone?
- How is NanoFlashing™ actually different from, and is it worth paying more than, an ordinary MERV-13 filter from a hardware store?
US federal regulatory category and claims
- What evidence establishes the regulatory category for each product and each advertised use?
- What intended uses and claims would change the regulatory position described for this product?
- What does each displayed federal identifier identify, and what does it fail to establish about performance or authorization?
- Have website pages, downloadable files, packaging and partner copy been checked for consistent claim scope?
- Which exact product, intended purpose and claim set support the company's reliance on the device definition in FIFRA section 2(h)?
- How does the current marketed product compare with the product and supporting materials addressed in the April determination?
- Is there a written agency disposition that withdraws, replaces or modifies the April determination, separate from later reported comments?
- Which current production establishments make each sold product, and what assigned establishment number belongs to each physical site?
- What production reports have actually been submitted for the establishments involved, and how do reported products and quantities match operating records?
- What current records demonstrate compliance with each continuing obligation applicable under 40 CFR 152.500?
- How was the overall impression of headings, surrounding text, comparisons and credentials assessed against 40 CFR 156.10(a)(5)?
- What evidence supports the physical-mechanism account while separately addressing the legal identity of the product that performs that mechanism?
- Which current pages, labels and promotional materials were actually included in each regulatory submission or review?
- Can a reported absence of registrations be reproduced in a documented primary-source search with a defined date and scope?
- How does the public account distinguish the text of law, agency guidance, a company legal argument and a product-specific decision?
- Does the agency correspondence identify the exact addressee entitled to rely on it?
- Can a confidential agency submission support a public claim broader than its stated question?
- Was the agency given all relevant composition information when the classification question was posed?
- Does an agency response contain conditions that are omitted from the company's summary?
- Would adding an ingredient that contributes a separate pesticidal effect change the classification analysis?
- Can an importer rely on a foreign manufacturer's establishment information without checking the imported configuration?
- Does offering a product at a US trade show create obligations before a sale occurs?
- Could an email sent with a quotation be considered part of the product's claims?
- Does a QR code on packaging lead to material that needs to be included in label review?
- Can archived web copy remain relevant to products still bearing a link to it?
- Would a co-packaged chemical treatment change the analysis of an otherwise physical device?
- Does the intended target claim distinguish a public-health use from another use category?
- Can a contractual disclaimer change the regulatory meaning of a prominent product claim?
- Who is authorised to respond to an EPA information request on behalf of each involved entity?
- Can the company obtain clarification of an ambiguous agency response without treating silence as agreement?
- Does a change in trade name require a different action from a change in composition?
- What record shows that a regulator's oral comment was confirmed accurately in writing?
- Can the company distinguish voluntary discussion with an agency from a formal decision process?
- Is NanoFlashing approved by the EPA or the FDA to fight COVID?
- Is the NanoFlashing™ Air Filter a pesticide?
- Why is the NanoFlashing™ Air Filter not registered with the EPA?
- The company “classifies” its own product under FIFRA and the EU Biocidal Products Regulation. Does that self-classification carry the same weight as an official government approval?
- Is it a pesticide?
EU finished products, online sales and national interfaces
- Which regulatory route applies to each product and intended use in each EU market?
- How has the company distinguished a material claim from a claim about the finished article's primary purpose?
- Which entity can supply the technical and compliance documents to authorities in the relevant market?
- What evidence addresses the physical-or-mechanical-action criterion in BPR Article 3 for the exact product placed on the market?
- How has the company kept its account of the physical mechanism consistent between US and EU materials?
- Which EU position document is current, and what record shows the status of earlier capture-only and later destruction wording?
- Has a competent authority issued any product-specific classification or authorization, or is the stated position currently the company's legal argument?
- If a treated-article route is asserted, what documents establish each relevant Article 58 condition for this exact article?
- What is the documented basis for any proposed transitional route, and does it establish every eligibility condition under the applicable version?
- Which Member State requirements have been checked beyond the EU-level legal analysis?
- What submitted files, case numbers, requested amendments or pending questions exist for the product in each relevant EU authority process?
- What review determines whether Article 72 advertising restrictions apply to the product and its proposed claims?
- Have the primary texts and product facts actually been checked before relying on another seller's legal position or a cited EU decision?
- What separate evidence establishes that each research application is ready for the particular EU intended use being proposed?
- What actions would follow if a competent authority rejected the claimed route or found that the advertised performance was unsupported?
- Which EU legislation actually requires CE marking for the proposed finished product?
- Can a supplier avoid implying that every filtration material is eligible for a CE mark?
- Does the declaration of conformity identify the complete product's applicable legislation?
- Who maintains the technical documentation for a private-label appliance sold in the EU?
- Can a marketplace listing identify the required responsible economic operator?
- Does an online offer give EU consumers the required product safety information before purchase?
- Would a connected purifier require a cybersecurity assessment alongside its filtration assessment?
- Can a PPE claim for a wearable filter be separated from a general hygiene claim?
- Would the proposed EU medical-device classification require notified-body assessment of the antimicrobial function or allow self-declaration?
- Would a food-contact use involve national measures beyond harmonised EU rules?
- Can an importer rely on a laboratory report that is not available in a language acceptable to the authority?
- Who handles safety notifications for an EU product sold under several brand names?
- Does a consumer-appliance return need separate handling from a material quality complaint?
- Can a withdrawn certification mark remain on goods manufactured before withdrawal?
- Would German public procurement require evidence different from permission to place the product on the market?
- Could French consumer labelling requirements affect the wording on a multilingual package?
- Does local market surveillance have access to the relevant confidential technical file?
- Can an EU free-movement argument resolve a product-specific safety objection raised by an authority?
- Is the European Commission's written answer of 16 December 2025 a legally binding ruling, or an informal opinion?
- Has any EU member state other than Italy, Spain and Belgium ruled on this kind of technology?
- Why does C-POLAR's EU regulatory statement cite four unrelated Italian companies' own marketing claims as supporting evidence?
EU chemicals and substance regimes
- Does the EU assessment identify whether the supplied item is treated as a substance, mixture or article for each relevant regime?
- Could REACH obligations apply independently of the proposed BPR classification?
- Is any intentionally released substance involved in the intended EU use?
- Are substance identities consistent between technical files and supplier safety documents?
- Does a claimed exemption under European chemicals law resolve every obligation for the complete product?
- Would any substance-of-concern disclosure duty attach to the supplied article?
- Is a SCIP assessment needed for the actual composition of an EU-supplied article?
- Can confidentiality be preserved while supplying legally required composition information?
- Does a nanomaterial description need a separate identity assessment under the applicable EU framework?
- Are upstream restrictions checked against the intended uses and exposure routes?
- Could a substance restriction affect stock already incorporated into finished goods?
- Does an EU distributor need a different information package from an industrial downstream user?
- Does an EU Only Representative appointment cover substance registration while leaving separate article duties with the importer?
- Are the duties attached to importing raw material distinguished from importing finished articles?
- Does a change in chemical supplier require updating substance identities in the compliance file?
- Can a food-contact claim rely on a substance list without evaluating the finished article?
- Would a water-contact application need a separate assessment of substances released into drinking water?
- Does disposal in the EU introduce obligations that are not settled by the product's market classification?
Exposure assessment and toxicology interpretation
- What supports absolute wording about ozone under every condition a buyer would reasonably infer?
- What information addresses released material or byproducts under foreseeable damage and wear?
- What evidence addresses skin-contact compatibility for the intended garment and wearing conditions?
- Which complete reports address eye and inhalation exposure for the exact finished material and use at issue?
- What evidence bridges the exposure assessment when a substrate, supplier, process or assembly component changes?
- Does a safety assessment distinguish the hazard of an ingredient from exposure to the finished article?
- Can an acute safety result support a claim about repeated long-term exposure?
- Does the assessment account for cumulative exposure from several products using the same material?
- Are local irritation and systemic toxicity evaluated as different endpoints?
- Does a negative skin-irritation result address the possibility of sensitisation?
- Can ingestion evidence be used to support an inhalation claim without a justified bridge?
- Does the assessment distinguish fibres, fragments and dissolved substances released from the material?
- Are particle-size distributions considered when interpreting inhalation exposure information?
- Does a safety assessment cover accidental damage as well as intact use?
- Can an assessment of an upstream ingredient account for impurities formed during processing?
- Are chronic endpoints excluded explicitly when they have not been evaluated?
- Does the evidence address genotoxic potential where relevant to the intended exposure?
- Could an ingredient's degradation products need a different assessment from the original ingredient?
- Is an estimated exposure based on realistic use frequency and service duration?
- Does the assessment identify uncertainty factors rather than hide them in a safe label?
- Can an independent assessor inspect the assumptions used to calculate a margin of safety?
- Does a non-detect for released material state the analytical detection capability?
- Can an animal study be interpreted without assuming identical exposure in humans?
- Does a safety conclusion for adults identify limits on extrapolation to other populations?
- Are alternative non-animal evidence sources evaluated for relevance to the actual endpoint?
- Can a supplier distinguish no observed effect from proof that no effect is possible?
- Does the assessment include emissions from the complete appliance's other components?
- Does NanoFlashing™ contain silver, copper, zinc or another metal?
- Does NanoFlashing™ contain or release nanoparticles?
Environmental fate and effects
- Does the environmental assessment distinguish the bound material from released fragments?
- Can the material's persistence be evaluated separately from its functional durability?
- Would treatment residues affect a wastewater plant's biological process?
- Does a biodegradation result identify whether the treated material or the whole composite was assessed?
- Can fragmenting into smaller pieces be mistaken for biodegradation?
- Does the assessment address accumulation in sediment as well as presence in water?
- Are effects on aquatic organisms assessed for the relevant released material?
- Could material retained in sewage sludge reach agricultural soil?
- Does composting evidence address the quality of the resulting compost?
- Can a product be considered recoverable while its captured contaminants remain environmentally problematic?
- Does an environmental risk assessment account for regional differences in waste treatment?
- Are manufacturing emissions included alongside releases during customer use?
- Can a claimed absence of leaching be distinguished from release below a test's detection limit?
- Does a weathering study identify the composition of the remaining fragments?
- Would a low total release still warrant assessment of a particularly hazardous constituent?
- Can a lifecycle benefit coexist with a local environmental burden that needs separate disclosure?
- Does the assessment consider accidental release of unused stock during transport?
- Can an independent environmental reviewer obtain the mass-balance assumptions behind a no-release claim?
Service levels and measured performance
- Can a service contract define the air or water performance to be maintained over time?
- Does a service-level promise measure response time or time to restore function?
- Can a supplier claim uptime while a unit runs below the agreed airflow?
- Does a monitoring plan use instruments accurate enough for the acceptance threshold?
- Can sensor placement be agreed before performance monitoring begins?
- How are unoccupied periods treated when calculating average room performance?
- Does a savings calculation adjust for weather and building occupancy?
- Can an energy baseline be recalculated after unrelated HVAC upgrades?
- Who owns the monitoring equipment at the end of the contract?
- Does the buyer receive raw monitoring data as well as a dashboard summary?
- Can missing monitoring periods be excluded without inflating a performance score?
- Does a service contractor have to report a bypassed or disabled unit promptly?
- Can maintenance quality be verified independently of the contractor's checklist?
- Does an outcome-based contract define who bears uncertainty in the measurement?
- Can seasonal performance shortfalls trigger a remedy even if the annual average passes?
- Does a monitoring contract include calibration and replacement of failed sensors?
- Can multiple sites be compared after accounting for differences in source strength and occupancy?
- Would a remote alert count as a completed service response before anyone visits the site?
- Can a customer dispute an automatically generated compliance report?
- Does the service contract specify what evidence is retained after termination?